Dr. Mohamed Adam is an assistant professor in the Department of Surgery at the University of California, San Francisco (UCSF). He is a surgical oncologist who has special expertise in the robotic approach, including robotic pancreaticoduodenectomy (Whipple procedure), as well as cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Dr. Adam earned his medical degree at Omdurman Islamic University in Sudan. He completed a residency in general surgery at Duke University Medical Center, where he also completed a research fellowship in advanced statistical modeling. He completed a fellowship in complex surgical oncology at the University of Pittsburgh Medical Center. Dr. Adam’s research focuses on leveraging translational artificial intelligence and machine learning algorithms to optimize cancer patients’ treatment. He has received many academic honors at Duke University and UCSF.
Dr. Mohamed Adam is an assistant professor in the Department of Surgery at the University of California, San Francisco (UCSF). He is a surgical oncologist who has special expertise in the robotic approach, including robotic pancreaticoduodenectomy (Whipple procedure), as well as cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Dr. Adam earned his medical degree at Omdurman Islamic University in Sudan. He completed a residency in general surgery at Duke University Medical Center, where he also completed a research fellowship in advanced statistical modeling. He completed a fellowship in complex surgical oncology at the University of Pittsburgh Medical Center. Dr. Adam’s research focuses on leveraging translational artificial intelligence and machine learning algorithms to optimize cancer patients’ treatment. He has received many academic honors at Duke University and UCSF.